Our Team
Robert C. Gorman, M.D.
Professor of Surgery
Robert Gorman is a Professor of Surgery at the University of Pennsylvania. His background is in engineering, cardiothoracic surgery, and general surgery. His research has been focused on the field of structural heart disease with an emphasis on post-infarction left ventricular remodeling, valvular heart disease, cardiovascular imaging, cardiovascular device development, and novel biomaterials.
Joseph H. Gorman, M.D.
Professor of Surgery Emeritus
Joseph H. Gorman is Professor of Surgery Emeritus at the University of Pennsylvania. Dr. Gorman has used his engineering, medical and surgical background to develop a research organization dedicated to the translation of research findings into more effective and less invasive therapies for structural heart and vascular disease.
Dr. Gorman’s research interests include the design and development of large animal models of cardiovascular disease, the pathophysiology and treatment of heart failure, pathophysiology of mitral valve disease, ventricular assist device design, percutaneous valve repair/replacement, design of heart valve repair and replacement devices, cardiac imaging with MRI, CT, real-time 3D echocardiography and NIR spectroscopy, mitral valve physiology, ventricular pacing for heart failure, valve calcification, and biocompatibility of synthetic surfaces.
Matthew J. Gillespie, M.D.
Professor of Pediatrics
Matthew J. Gillespie is Professor of Pediatrics at the University of Pennsylvania School of Medicine, and an Attending interventional cardiologist serving as the Director of the Cardiac Catheterization Laboratory at the Children’s Hospital of Philadelphia. His clinical and research interests center on minimally invasive, catheter-based interventions for the treatment of structural heart defects in children and adults. His primary research interest has been focused on developing novel devices and percutaneous treatment strategies for diseased heart valves, and other congenital and acquired cardiovascular pathologies. Currently, his main focus is on percutaneous valve replacement for complex pulmonary and mitral valve disorders, as well as on developing adjuvant technologies designed to make percutaneous valve therapies safer and more effective.